CN113214158A - Preparation method of 2-trifluoromethyl imidazoline compound - Google Patents

Preparation method of 2-trifluoromethyl imidazoline compound Download PDF

Info

Publication number
CN113214158A
CN113214158A CN202110644644.4A CN202110644644A CN113214158A CN 113214158 A CN113214158 A CN 113214158A CN 202110644644 A CN202110644644 A CN 202110644644A CN 113214158 A CN113214158 A CN 113214158A
Authority
CN
China
Prior art keywords
trifluoromethyl
reaction
trifluoromethylimidazoline
imidazoline
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110644644.4A
Other languages
Chinese (zh)
Inventor
王慧
陈铮凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Vocational and Technical College
Original Assignee
Hangzhou Vocational and Technical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Vocational and Technical College filed Critical Hangzhou Vocational and Technical College
Priority to CN202110644644.4A priority Critical patent/CN113214158A/en
Publication of CN113214158A publication Critical patent/CN113214158A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention discloses a preparation method of a 2-trifluoromethyl imidazoline compound, which comprises the following steps: adding N-iodosuccinimide, a 4A molecular sieve, trifluoroethylimidoyl chloride and allyl amine into an organic solvent, reacting at room temperature for 1-2 hours completely, and performing post-treatment to obtain the 2-trifluoromethyl imidazoline compound. The preparation method is simple to operate, the initial raw materials are cheap and easy to obtain, the reaction conditions are mild, the reaction time is short, the reaction does not need to be operated under the anhydrous and anaerobic conditions, heavy metals are not used as catalysts, the reaction can be expanded to gram level, imidazoline compounds with trifluoromethyl groups, which are variously substituted at different positions, can be synthesized through substrate design, and the applicability of the method is expanded while the operation is convenient.

Description

Preparation method of 2-trifluoromethyl imidazoline compound
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a 2-trifluoromethyl imidazoline compound.
Background
Imidazoline compounds are important five-membered nitrogen-containing heterocycles with a wide range of biological and pharmaceutical activities, such as anti-cancer, anti-inflammatory, anti-diabetic and anti-hypertensive activities (j.med.chem.2009,52,1302). Some imidazoline structures can also be used as synthesis intermediates, organic adjuvants, and chiral ligands (org. lett.2020,22,2868). Therefore, many synthetic methods have been developed to construct such important nitrogen-containing heterocyclic compounds.
Figure BDA0003108649330000011
The traditional methods for preparing imidazolines reported in the literature today are the Heine reaction and related methods derived from the Heine reaction. These methods have the disadvantages of various synthetic steps and low total reaction yield. In addition, efficient synthesis methods have not been widely reported for some specially functionalized imidazoline compounds, such as trifluoromethyl substituted imidazolines.
Based on the method, a method for synthesizing 2-trifluoromethyl imidazoline simply and efficiently by using allyl amine and trifluoroethylimidoyl chloride which are simple and easy to obtain as starting materials and performing iodo cyclization reaction promoted by N-iodo succinimide is developed.
Disclosure of Invention
The invention provides a preparation method of a 2-trifluoromethyl imidazoline compound, which has the advantages of simple steps, cheap and easily-obtained starting raw materials, mild reaction conditions, short reaction time, no need of anhydrous and anaerobic conditions, avoidance of the use of toxic heavy metal catalysts and convenience in operation and application; the reaction can be easily expanded to gram-scale reaction, and the iodomethyl in the product is easy to be subjected to derivatization, so that the possibility is provided for future large-scale production and application.
A preparation method of a 2-trifluoromethyl imidazoline compound comprises the following steps: adding N-iodosuccinimide, a 4A molecular sieve, trifluoroethylimidoyl chloride and allyl amine into an organic solvent, reacting at room temperature for 1-2 hours completely, and performing post-treatment to obtain the 2-trifluoromethyl imidazoline compound;
the structure of the trifluoroethylimidoyl chloride is shown as a formula (II):
Figure BDA0003108649330000021
the allyl amine has a structure shown in formula (III):
Figure BDA0003108649330000022
the structure of the 2-trifluoromethyl imidazoline compound is shown as the formula (I):
Figure BDA0003108649330000023
in formulae (I) to (III), R1Is a substituted or unsubstituted aryl group;
R2is H, C1~C4Alkyl, substituted or unsubstituted aryl;
at R1Wherein the substituents on the aryl group are selected from C1~C4Alkyl radical, C1~C4Alkoxy, halogen or trifluoromethyl.
The equivalent of the N-iodosuccinimide is 1-3 equivalents;
R1the substitution position of the upper aryl group can be ortho-position, para-position or meta-position.
The reaction formula is exemplified as follows:
Figure BDA0003108649330000031
during the reaction, firstly, the coupling reaction of trifluoroethylimidoyl chloride and allylamine is probably carried out to generate an amidine intermediate, then N-iodosuccinimide and a double bond are subjected to iodination reaction to obtain a ternary iodonium ion, and then intramolecular nucleophilic attack and deprotonation are carried out to obtain the final 2-trifluoromethyl imidazoline compound. The reaction may proceed by ionic processes.
In the present invention, the optional post-processing procedure includes: filtering, mixing the sample with silica gel, and finally performing column chromatography purification to obtain the corresponding 2-trifluoromethyl imidazoline compound, wherein the column chromatography purification is a technical means commonly used in the field.
Preferably, R1The substituted or unsubstituted phenyl is selected from methyl, methoxy, bromine or trifluoromethyl, and in this case, the aromatic amine and the trifluoroethylimidoyl chloride are easily obtained and the reaction yield is high.
Preferably, R2H, methyl, phenyl or naphthyl, in which case the allylamine is readily prepared and the reaction yields are high.
Preferably, the iodide is N-iodosuccinimide, which is used in the reaction at a high yield.
Preferably, the 4A molecular sieve is used as the additive, the molecular sieve is cheaper and commonly used, and the reaction yield is higher.
The allylamine is relatively easy to prepare, and is preferably used in excess of the p-trifluoroethylimidoyl chloride, and the molar ratio of trifluoroethylimidoyl chloride: allyl amine: n-iodosuccinimide is 1: 2-3: 1-3; as a further preference, the molar amount of trifluoroethylimidoyl chloride: allyl amine: n-iodosuccinimide ═ 1:2.5: 2.
In the present invention, the organic solvent capable of sufficiently dissolving the raw material can cause the reaction, but the difference in reaction efficiency is large, and the aprotic solvent is preferably an aprotic solvent which can effectively promote the reaction; preferably, the organic solvent is acetonitrile, DMSO or DMF; more preferably, the organic solvent is acetonitrile, in which case the starting materials are converted to the product in high conversion.
The amount of the organic solvent can be used for better dissolving the raw materials, and the amount of the organic solvent used for 1mmol of trifluoroethylimidoyl chloride is about 5-10 mL.
Preferably, the iodide is N-iodosuccinimide, and the reaction efficiency is high when the N-iodosuccinimide is used as an accelerator.
As a further preference, the 2-trifluoromethyl imidazoline compound is one of the compounds shown in the formula (I-1) and the formula (I-5):
Figure BDA0003108649330000041
in the preparation method, the aromatic amine, the individual allylamine and the N-iodosuccinimide are generally commercially available products and can be conveniently obtained from the market, and the trifluoroethylimidoyl chloride can be quickly synthesized from the corresponding aromatic amine, triphenylphosphine, carbon tetrachloride and trifluoroacetic acid.
Compared with the prior art, the invention has the beneficial effects that: the preparation method does not need anhydrous and anaerobic conditions, has room temperature reaction, high reaction efficiency, easy operation and simple and convenient post-treatment, and can expand the reaction to gram level; the reaction starting raw materials are cheap and easy to obtain, the designability of the reaction substrate is strong, the tolerance range of the substrate functional group is wide, different substituted imidazoline compounds can be designed and synthesized according to actual needs, and the practicability is strong.
Detailed Description
The invention is further described with reference to specific examples.
Examples 1 to 15
Adding N-iodosuccinimide, a 4A molecular sieve, trifluoroethylimidoyl chloride (II), allyl amine (III) and 2mL of an organic solvent into a 35mL Schlenk tube according to the raw material ratio of Table 1, mixing and stirring uniformly, reacting according to the reaction conditions of Table 2, filtering after the reaction is finished, mixing a sample with silica gel, and purifying by column chromatography to obtain a corresponding 2-trifluoromethyl imidazoline compound (I), wherein the reaction process is shown as the following formula:
Figure BDA0003108649330000051
TABLE 1 raw material addition amounts of examples 1 to 15
Figure BDA0003108649330000052
TABLE 2
Figure BDA0003108649330000053
Figure BDA0003108649330000061
In tables 1 and 2, T is the reaction temperature, T is the reaction time, Ph is phenyl, Me is methyl, SMe is methylthio, and T-Bu is tert-butyl.
Structure confirmation data of the compounds prepared in examples 1 to 5:
nuclear magnetic resonance of 2-trifluoromethylimidazoline Compound (I-1) prepared in example 1 (II-1)1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0003108649330000062
1H NMR(400MHz,CDCl3)δ7.22(s,4H),4.15(d,J=17.1Hz,1H),3.96(d,J=17.1Hz,1H),3.28(d,J=10.7Hz,1H),3.21(d,J=10.7Hz,1H),2.40(s,3H),1.47(s,3H).
13C{1H}NMR(101MHz,CDCl3)δ152.6(C-F,q,2JC-F=35.7Hz),139.5,131.0,130.1,129.9,117.2(C-F,q,1JC-F=276.5Hz),67.8,65.4,24.6,21.1,15.8.
19F NMR(377MHz,CDCl3)δ-65.8.
M.p.112.4-113.5℃
HRMS(ESI):[M+H]+Calcd.for C13H14F3IN2 383.0227;Found 383.0236.
nuclear magnetic resonance of 2-trifluoromethylimidazoline Compound (I-2) prepared in example 2 ((II-2))1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0003108649330000071
1H NMR(400MHz,CDCl3)δ7.32(s,1H),7.14(t,J=8.2Hz,1H),4.17(d,J=16.7Hz,1H),3.92(d,J=16.5Hz,1H),3.24(q,J=10.7Hz,1H),1.45(s,2H)
13C{1H}NMR(101MHz,CDCl3)δ162.7(C-F,d,1JC-F=250.1Hz),152.1(C-F,q,2JC-F=35.5Hz),152.2,151.9,132.4(C-F,d,3JC-F=8.8Hz),130.4,117.4(C-F,q,1JC-F=286.2Hz),117.2,116.2(C-F,q,2JC-F=22.7Hz),67.4,66.7,24.6,15.7.
19F NMR(377MHz,CDCl3)δ-111.3,-65.8.
HRMS(ESI):[M+H]+Calcd.for C12H11F4IN2 386.9976;Found 386.9984.
nuclear magnetic resonance of 2-trifluoromethylimidazoline Compound (I-3) prepared in example 3 ((II-3))1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0003108649330000072
1H NMR(400MHz,CDCl3)δ7.71(d,J=8.4Hz,2H),7.44(d,J=8.2Hz,2H),4.18(d,J=17.8Hz,1H),3.93(d,J=17.7Hz,1H),3.23(q,J=10.8Hz,1H),1.45(s,3H).
13C{1H}NMR(101MHz,CDCl3)δ151.7(C-F,q,2JC-F=35.7Hz),138.2,131.1(C-F,q,2JC-F=33.0Hz),130.7,126.4,123.6(C-F,q,1JC-F=272.3Hz),117.4(C-F,q,1JC-F=275.7Hz),67.8,66.9,24.6,15.5.
19F NMR(377MHz,CDCl3)δ-62.7,-65.5.
M.p.102.4–104.3℃
HRMS(ESI):[M+H]+Calcd.for C13H11F6IN2 436.9944;Found 436.9950.
nuclear magnetic resonance of 2-trifluoromethylimidazoline Compound (I-4) prepared in example 4 (II)1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0003108649330000081
1H NMR(400MHz,CDCl3)δ7.28–6.86(m,4H),4.12(d,J=17.2Hz,1H),3.86(d,J=20.6Hz,4H),3.25(d,J=10.6Hz,1H),3.17(d,J=10.5Hz,1H),1.41(s,3H).
13C{1H}NMR(101MHz,CDCl3)δ157.8(C-F,q,2JC-F=37.3Hz),130.2,130.1,129.1,115.7(C-F,q,1JC-F=287.7Hz),114.9,113.4,53.1,44.2,20.5,9.7.
19F NMR(377MHz,CDCl3)δ-75.6.
HRMS(ESI):[M+H]+Calcd.for C11H10F3IN2 369.0070;Found 369.0068.
nuclear magnetic resonance of 2-trifluoromethylimidazoline Compound (I-5) prepared in example 5 (II)1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0003108649330000082
1H NMR(400MHz,CDCl3)δ7.44–7.17(m,5H),6.96(d,J=8.1Hz,2H),6.68(d,J=7.9Hz,2H),4.62(d,J=17.9Hz,1H),4.46(d,J=18.3Hz,1H),3.72(q,J=10.6Hz,2H),2.27(s,3H).
13C{1H}NMR(101MHz,CDCl3)δ152.4(C-F,q,2JC-F=35.3Hz),140.4,138.8,131.6,129.8,129.4,128.7,128.5,127.0,117.6(C-F,q,1JC-F=275.7Hz),71.9,69.6,21.1,13.3.
19F NMR(377MHz,CDCl3)δ-65.5.
M.p.118.3–119.2℃.
HRMS(ESI):[M+H]+Calcd.for C18H16F3IN2 445.0383;Found 445.0390.

Claims (8)

1. a preparation method of a 2-trifluoromethyl imidazoline compound is characterized by comprising the following steps: adding an iodide, an additive, trifluoroethylimidoyl chloride and allyl amine into an organic solvent, reacting at room temperature for 1-2 hours, and performing post-treatment to obtain the 2-trifluoromethyl imidazoline compound;
the structure of the trifluoroethylimidoyl chloride is shown as a formula (II):
Figure FDA0003108649320000011
the allyl amine has a structure shown in formula (III):
Figure FDA0003108649320000012
the structure of the 2-trifluoromethyl imidazoline compound is shown as the formula (I):
Figure FDA0003108649320000013
in formulae (I) to (III), R1Is a substituted or unsubstituted aryl group;
R2is H, C1~C4Alkyl, substituted or unsubstituted aryl;
at R1Wherein the substituents on the aryl group are selected from C1~C4Alkyl radical, C1~C4Alkoxy radical, C1~C4Alkylthio, halogen or trifluoromethyl;
at R2In (1), the substituent on the aryl group is halogen.
2. The method for producing 2-trifluoromethylimidazoline compound according to claim 1, wherein R is1Is substituted or unsubstituted phenyl;
the substituent on the phenyl is selected from methyl, methoxy, bromine or trifluoromethyl.
3. The method for producing 2-trifluoromethylimidazoline compound according to claim 1, wherein R is2Is H, methyl, substituted or unsubstituted phenyl or naphthyl;
the substituent on the phenyl group is Cl.
4. The method for producing a 2-trifluoromethylimidazoline compound according to claim 1, wherein the molar amount of trifluoroethylimidoyl chloride: allyl amine: the iodide is 1:2 to 3:1 to 3.
5. The method for preparing 2-trifluoromethylimidazoline compound according to claim 1, wherein the organic solvent is acetonitrile.
6. The method for preparing 2-trifluoromethylimidazoline compound according to claim 1, wherein the iodide is N-iodosuccinimide.
7. The method for preparing 2-trifluoromethyl imidazoline compound according to claim 1, wherein the additive is 4A molecular sieve.
8. The method for preparing a 2-trifluoromethylimidazoline compound according to claim 1, wherein the 2-trifluoromethylimidazoline compound is one of compounds represented by formula (I-1) to formula (I-5):
Figure FDA0003108649320000021
CN202110644644.4A 2021-06-09 2021-06-09 Preparation method of 2-trifluoromethyl imidazoline compound Withdrawn CN113214158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110644644.4A CN113214158A (en) 2021-06-09 2021-06-09 Preparation method of 2-trifluoromethyl imidazoline compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110644644.4A CN113214158A (en) 2021-06-09 2021-06-09 Preparation method of 2-trifluoromethyl imidazoline compound

Publications (1)

Publication Number Publication Date
CN113214158A true CN113214158A (en) 2021-08-06

Family

ID=77083471

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110644644.4A Withdrawn CN113214158A (en) 2021-06-09 2021-06-09 Preparation method of 2-trifluoromethyl imidazoline compound

Country Status (1)

Country Link
CN (1) CN113214158A (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ELHAM KAZEMI ET AL.: ""Intramolecular oxidative cyclization of N-(2,2,2-trifluoro-1-(phenylimino)ethyl)benzimidamide"", 《MOLECULAR DIVERSITY》 *
SHAN LI ET AL.: ""Iodine-mediated aminohalogenation-oxidation to synthesize 2-fluoroalkyl imidazole derivatives"", 《CHEMICAL PAPERS》 *
YUFEI SONG ET AL.: ""The cascade coupling/iodoaminocyclization reaction of trifluoroacetimidoyl chlorides and allylamines: metal-free access to 2-trifluoromethyl-imidazolines"", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 *

Similar Documents

Publication Publication Date Title
CN111978265B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole derivative
CN111675662B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound
CN113105402B (en) Preparation method of 3,4, 5-trisubstituted 1,2, 4-triazole compound
CN113307790B (en) Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN110467579B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole compound
CN111423381B (en) Preparation method of 2-trifluoromethyl substituted imidazole compound
CN113121462B (en) Preparation method of 5-trifluoromethyl substituted 1,2,3-triazole compound
CN113307778A (en) Preparation method of 3-trifluoromethyl substituted 1,2, 4-triazole compound
CN112125856A (en) Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN112480015B (en) Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045503B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound and application of compound in synthesis of drug molecules
CN113735778A (en) Preparation method of 5-trifluoromethyl substituted imidazole compound
CN113880781B (en) Method for synthesizing 3-trifluoromethyl substituted 1,2, 4-triazole compound by taking glucose as carbon source
CN110922369A (en) Trifluoromethyl substituted dihydrofuran amine compound and preparation method and application thereof
CN115772157A (en) Preparation method of 2-alkoxy indole compound
CN113214158A (en) Preparation method of 2-trifluoromethyl imidazoline compound
CN115286578A (en) Preparation method of pyrazole compound containing trifluoromethyl
CN113636968A (en) Synthetic method of 3-acyl pyrrole compound
CN114195726B (en) Preparation method of 1,2, 4-triazole substituted arylamine compound
CN115215810B (en) Preparation method of heating-promoted 5-trifluoromethyl-substituted 1,2, 4-triazole compound
CN115353482B (en) Preparation method of trifluoromethyl and selenium substituted azaspiro [4,5] -tetraenone compound
CN114920707B (en) Preparation method of 3-trifluoromethyl substituted 1,2,4-triazole compound
CN113072510A (en) Green preparation method of 1,2, 4-triazole-3-ketone compound
CN109988114B (en) Preparation method of polysubstituted 4, 5-dihydropyrazole compound
CN116253692A (en) Preparation method of trifluoromethyl substituted 1,2, 4-triazine compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210806

WW01 Invention patent application withdrawn after publication